Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Frontiers in Immunology|June 14, 2024
Newcastle disease virus vector-based SARS-CoV-2 vaccine candidate AVX/COVID-12 activates T cells and is recognized by antibodies from COVID-19 patients and vaccinated individualsAlejandro Torres-Flores, Luis Alberto Ontiveros-Padilla, Ruth Lizzeth Madera-Sandoval, et al.
Cancer Research|August 5, 2022
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy CombinationsJesse Boumelha, Sophie de Carné Trécesson, Emily K Law, et al.
Science (New York, N.Y.)|February 19, 2026
The oncogenome of the domestic catBailey A Francis, Latasha Ludwig, Chang He, et al.
Microbiome|May 14, 2024
Dietary fibre supplementation enhances radiotherapy tumour control and alleviates intestinal radiation toxicityChee Kin Then, Salome Paillas, Aliu Moomin, et al.
Vaccine|November 11, 2024
Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 "Patria" recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in MexicoConstantino López-Macías, Martha Torres, Brenda Armenta-Copca, et al.
Medrxiv : the Preprint Server for Health Sciences|February 16, 2022
Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in MexicoSamuel Ponce-de-León, Martha Torres, Luis Enrique Soto-Ramírez, et al.
Cancer Discovery|March 4, 2026
Targeting the lipid metabolism proteins FASN and GPAM in alveolar type II cells decreases lung metastasisXiao-Zheng Liu, Yulia Panina, Weigang Cai, et al.
Science (New York, N.Y.)|April 25, 2024
Vitamin D regulates microbiome-dependent cancer immunityEvangelos Giampazolias, Mariana Pereira da Costa, Khiem C Lam, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 20, 2024
Synergistic impact of innate immunity hyper-activation and endothelial dysfunction on the magnitude of organ failure in the infection-sepsis continuumAmanda de la Fuente, Jaime López-Sánchez, Luis Mario Vaquero-Roncero, et al.
NPJ Vaccines|May 10, 2023
Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in MexicoSamuel Ponce-de-León, Martha Torres, Luis Enrique Soto-Ramírez, et al.
Pageof 13